Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
Intas Pharma, Syna Therapeutics ink pact for commercialization of LB-0702 in Global Markets Ruchika Sharma6 Nov 2022 2:00 PM ISTAhmedabad: Syna Therapeutics, a joint venture of Reig Jofre and Leanbio, has signed a global rights licensing deal with Intas Pharmaceuticals...
Anti-trust regulator CCI clears Abu Dhabi Investment Authority minority stake acquisition in Intas Pharma Ruchika Sharma11 Oct 2022 11:15 AM ISTNew Delhi: Anti-trust regulator Competition Commission of India (CCI) has cleared Platinum Owl's acquisition of a minority stake in Intas...
Intas Pharma, Comera Life Sciences ink pact for bio-innovative biologic medicines Ruchika Sharma20 April 2022 11:19 AM ISTAhmedabad: Comera Life Sciences, Inc. and Intas Pharmaceuticals Ltd. have announced a research collaboration to develop a new...
Intas Pharma, Axantia collaborate for Ranibizumab in Middle East Ruchika Sharma5 April 2022 12:20 PM ISTIntas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA and the...
Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharma unveils antifungal drug SB-100mg Itraconazole Roshni Dhar21 Oct 2021 4:40 PM ISTIn a progressive breakthrough in the Antifungal Therapy domain, Intas Pharmaceuticals has launched the world's first Super Bioavailable...
First: Intas Pharma launches antifungal drug SB-100mg Itraconazole Ruchika Sharma18 Oct 2021 11:45 AM ISTPatients can take Itaspor SB Forte/ Subawin with or without a meal with just water or as directed by the physician.
FIRST: Intas Pharma launches Oral Azacitidine under brand name Azadine-O Ruchika Sharma26 Sept 2021 10:15 AM ISTAhmedabad: In a significant development, drugmaker Intas Pharma has announced the launch of Oral Azacitidine in India under the brand name of...
Intas Pharma, Meiji, Dong-A ST ink licensing agreement for biosimilar to Ustekinumab Ruchika Sharma24 July 2021 9:00 AM ISTAhmedabad: Intas Pharmaceuticals Ltd has announced that the company has entered into an exclusive license agreement with Meiji and Dong-A Socio...
NPPA panel fixes price of Intas Pharma oncology drug, Details Medical Dialogues Team27 Jun 2021 10:15 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of an oncology drug combination pack of...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
